EXHIBIT 32.2

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Enox Biopharma,  Inc. (the "Company")
on Form  10-Q for the  period  ended  September  30,  2010,  as  filed  with the
Securities  and  Exchange  Commission  on the date  hereof (the  "Report"),  the
undersigned,  as the Chief Financial  Officer of the Company,  hereby  certifies
pursuant to 18 U.S.C.  Section 1350,  as adopted  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

     (1)  the Report fully  complies with the  requirements  of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.


Date: November 15, 2010                    By: /s/ Itamar David
                                               ---------------------------------
                                               Itamar David
                                               Chief Financial Officer
                                               (Principal Financial Officer)